Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer

BACKGROUND: A phase-III trial showed the non-inferiority of oral capecitabine plus oxaliplatin (XELOX) vs 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) in terms of efficacy in first-line treatment of metastatic colorectal cancer. A secondary objective was to compare the quality of life (QoL)...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Conroy, T, Hebbar, M, Bennouna, J, Ducreux, M, Ychou, M, Llédo, G, Adenis, A, Faroux, R, Rebischung, C, Kockler, L, Douillard, J Y
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 2010
Teme:
Clinical Study
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC2813741/
https://ncbi.nlm.nih.gov/pubmed/19920832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/sj.bjc.6605442
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki